Literature DB >> 9266973

DNA-conformation is an important determinant of sequence-specific DNA binding by tumor suppressor p53.

E Kim1, N Albrechtsen, W Deppert.   

Abstract

Sequence-specific transactivation of target genes is one of the most important molecular properties of the tumor suppressor p53. Binding of p53 to its target DNAs is tightly regulated, with modifications in the carboxy-terminal regulatory domain of the p53 protein playing an important role. In this study we examined the possible influence of DNA structure on sequence-specific DNA binding by p53, by analysing its binding to p53 consensus elements adopting different conformations. We found that p53 has the ability to bind to consensus elements which are present in a double-helical form, as well as to consensus elements which are located within alternative non-B-DNA structures. The ability of a consensus element to adopt either one of these conformations is dependent on its sequence symmetry, and is strongly influenced by its sequence environment. Our data suggest a model according to which the conformational status of the target DNA is an important determinant for sequence-specific DNA binding by p53. Modifications in the carboxy-terminal regulatory region of p53 possibly determine the preference of p53 for a given DNA conformation.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9266973     DOI: 10.1038/sj.onc.1201412

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  15 in total

1.  Different regulation of the p53 core domain activities 3'-to-5' exonuclease and sequence-specific DNA binding.

Authors:  F Janus; N Albrechtsen; U Knippschild; L Wiesmüller; F Grosse; W Deppert
Journal:  Mol Cell Biol       Date:  1999-03       Impact factor: 4.272

2.  Efficient specific DNA binding by p53 requires both its central and C-terminal domains as revealed by studies with high-mobility group 1 protein.

Authors:  Kristine McKinney; Carol Prives
Journal:  Mol Cell Biol       Date:  2002-10       Impact factor: 4.272

3.  A role for DNA-mediated charge transport in regulating p53: Oxidation of the DNA-bound protein from a distance.

Authors:  Katherine E Augustyn; Edward J Merino; Jacqueline K Barton
Journal:  Proc Natl Acad Sci U S A       Date:  2007-11-19       Impact factor: 11.205

4.  Specific mismatch recognition in heteroduplex intermediates by p53 suggests a role in fidelity control of homologous recombination.

Authors:  C Dudenhöffer; G Rohaly; K Will; W Deppert; L Wiesmüller
Journal:  Mol Cell Biol       Date:  1998-09       Impact factor: 4.272

5.  Specific interaction of mutant p53 with regions of matrix attachment region DNA elements (MARs) with a high potential for base-unpairing.

Authors:  K Will; G Warnecke; L Wiesmüller; W Deppert
Journal:  Proc Natl Acad Sci U S A       Date:  1998-11-10       Impact factor: 11.205

6.  Rapid and Sensitive Detection of p53 Based on DNA-Protein Binding Interactions Using Silver Nanoparticle Films and Microwave Heating.

Authors:  Muzaffer Mohammed; Kadir Aslan
Journal:  Nano Biomed Eng       Date:  2014-11-10

7.  Redox state of tumor suppressor p53 regulates its sequence-specific DNA binding in DNA-damaged cells by cysteine 277.

Authors:  Jiri Buzek; Leena Latonen; Sari Kurki; Karita Peltonen; Marikki Laiho
Journal:  Nucleic Acids Res       Date:  2002-06-01       Impact factor: 16.971

8.  Tracing the protectors path from the germ line to the genome.

Authors:  Daniel Coutandin; Horng Der Ou; Frank Löhr; Volker Dötsch
Journal:  Proc Natl Acad Sci U S A       Date:  2010-08-09       Impact factor: 11.205

9.  Characterization of structural p53 mutants which show selective defects in apoptosis but not cell cycle arrest.

Authors:  K M Ryan; K H Vousden
Journal:  Mol Cell Biol       Date:  1998-07       Impact factor: 4.272

10.  A flexible integrative approach based on random forest improves prediction of transcription factor binding sites.

Authors:  Bart Hooghe; Stefan Broos; Frans van Roy; Pieter De Bleser
Journal:  Nucleic Acids Res       Date:  2012-04-05       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.